Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc. Abbvie currently holds 1,190,473 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Abbvie has been a net seller of RETA stock. They have purchased $0 and sold $10.1M worth of shares.
Inc. Abbvie's most recent insider trade was on Mar 28, 2017, when they sold 450,000 shares at $22.50 per share.
Inc. Abbvie serves as Executive at REATA PHARMACEUTICALS INC (RETA). They have executed 2 insider transactions totaling $10.1M over their tenure at the company.
Inc. Abbvie holds the position of Executive at REATA PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Inc. Abbvie has shown a selling trading pattern, with $0 in total purchases and $10.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Inc. Abbvie was on Mar 28, 2017, when they sold $10.1M worth of RETA shares. This transaction involved 450,000 shares at $22.50 per share.
Inc. Abbvie currently owns 1,190,473 shares of REATA PHARMACEUTICALS INC (RETA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc. Abbvie's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc. Abbvie has 2 Form 4 filings on record as an insider at REATA PHARMACEUTICALS INC.
Set alerts for Inc. Abbvie and 40,000+ other insiders.